Anglade Eddy
Insider CIK 1596179 · ACTC EVP of Clinical Development
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 112,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | D To issuer deriv | 2016-02-10 | 2016-02-11 | 100,000 | — | $0 | 0 | SEC↗ |
| OCAT Ocata Therapeutics, Inc. | U Tender | 2016-02-10 | 2016-02-11 | 56,000 | $8.50 | $476.0K | 0 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | A Award deriv | 2014-09-12 | 2014-09-16 | 112,000 | — | $0 | 212,000 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | A Award deriv | 2014-09-12 | 2014-09-18 | 112,000 | — | $0 | 112,000 | SEC↗ |
| ACTCD ADVANCED CELL TECHNOLOGY, | A Award | 2014-09-12 | 2014-09-16 | 56,000 | — | $0 | 56,000 | SEC↗ |
| ACTC ADVANCED CELL TECHNOLOGY, | A Award deriv | 2014-02-04 | 2014-02-06 | 10,000,000 | — | $0 | 10,000,000 | SEC↗ |